Quest Diagnostics Inc (DGX) Stock Price & Analysis

Quest Diagnostics Inc (DGX) rose 0.00% to USD 227.86 as of July 25, 2026 at 02:23 UTC, according to Nexqual real-time market data.

DGX last closed at USD 227.86; the session ranged USD 223.42–233.21 on volume of 1,330,197 shares. Market capitalization is —, with a 52-week range of USD 165.78–237.78 (NYQ). Source: Nexqual, July 25, 2026 at 02:23 UTC.

Key Statistics (as of July 25, 2026 at 02:23 UTC)

Technical Analysis (DGX)

Nexqual's technical model rates DGX "BUY" based on 5 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 02:23 UTC.

From Quest Diagnostics Inc's Latest SEC 10-K Filing (filed 2026-02-26)

Key Strengths & Strategy (as disclosed to the SEC)

• In 2025, our Collaborative Lab Solutions (formerly known as Professional Laboratory Services) offering generated approximately $800 million in revenues and management fees supporting hospitals in the operation of their own labs.
• In 2025, we generated approximately $1.2 billion in revenue from "reference testing," where we perform testing that hospitals do not perform in their own in-hospital labs. • Helping hospitals operate their labs more efficiently.
• Our services primarily are provided under the Quest Diagnostics brand, but we also provide services under other brands, including AmeriPath, ® Dermpath Diagnostics, ® ExamOne, ® and Quanum. ®     We are a leading provider of diagnostic information services in the United States, where we conduct substantially all of our business.
• We see opportunities to bring our experience and expertise in diagnostic information services to markets outside the United States, including leveraging existing facilities to serve new markets. 8 Table of Contents Diagnostic Information Services          Background - clinical testing.

Partnerships

• In 2025, we announced a collaboration with Google to use Google Cloud's data analytics and generative AI to help us streamline our data management, improve data analytics, and personalize the experiences we deliver to patients, providers, and other customers.     We are committed to using AI in an ethical, responsible and compliant way.
• The value delivery side includes sales, laboratory operations, field operations, logistics and client services. 5 Table of Contents Assets and Capabilities that Deliver Value     We collaborate with partners and customers across the healthcare ecosystem to help create a healthier world.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:23 UTC. This page is informational and not investment advice.